Ovasave is an Abu Dhabi-based femtech startup dedicated to advancing women's reproductive health through digital solutions. Founded in 2023 by Majd Abu Zant and Torkia Mahloul, the company focuses on at-home hormone testing, virtual consultations, and personalized supplement protocols, with a particular emphasis on fertility and hormonal health. As of July 2025, Ovasave has raised $1.2 million in a pre-seed funding round led by PlusVC, Annex Investments, and New York-based 25 Madison.
| Attribute | Information |
|---|---|
| Founding Date | 2023 |
| Headquarters | Abu Dhabi, United Arab Emirates |
| Founders | Majd Abu Zant, Torkia Mahloul |
| Revenue | Not disclosed |
| Profits | Not disclosed |
| Key Investors | PlusVC, Annex Investments, 25 Madison |
| Industry | Femtech |
| Number of Employees | Approximately 4 |
Ovasave emerged in 2023 from the personal fertility journeys of its founders, Majd Abu Zant and Torkia Mahloul. After recognizing a significant gap in accessible fertility management solutions, they created a platform that integrated digital technology with healthcare services. Their aim was to provide women with comprehensive and affordable access to fertility-related products and services, such as hormone testing and egg freezing. Recognized early for its innovative approach, Ovasave garnered attention from Abu Dhabi's Hub71 tech ecosystem, helping it to gain momentum and initial funding.
Ovasave's platform is built around providing women with seamless access to fertility and hormonal health services through a digital-first approach. Key offerings include:
Ovasave's strategic partnerships with organizations like Hub71 have been central to its growth, providing access to crucial resources and partners. The company has also fostered a strong corporate culture around women's empowerment, extending their services into the corporate wellness domain, which promotes fertility awareness at workplaces.
Operating primarily in the MENA region, Ovasave has made significant strides in the femtech industry. The company's services cater to a growing demand for reproductive health solutions that are both sophisticated and accessible. They focus on expanding their regional footprint with a well-crafted plan tailored to the unique demographic needs and challenges of the Middle East.
Ovasave stands out in the femtech sector for its commitment to revolutionizing women's reproductive health through technology and accessibility. By adopting a holistic approach to fertility management that caters to modern women's realities, Ovasave is poised to lead significant change in fertility healthcare, challenging traditional healthcare frameworks. As the company expands its influence across the GCC, leveraging collaboration, and continuous innovation, it is well-positioned to become a cornerstone in women’s health and wellness initiatives in the region.